Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Neoplasms 19 Endometrial Neoplasms 14 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Breast Neoplasms 5 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Melanoma 4 Lung Neoplasms 4 Colonic Neoplasms 4 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Recurrence 2 Osteosarcoma 2 Multiple Myeloma 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Small Cell Lung Carcinoma 1

Interventions

Pemetrexed 39 Cisplatin 33 pembrolizumab 21 Nivolumab 17 Carboplatin 16 Ipilimumab 13 Gemcitabine 10 Cyclophosphamide 9 fludarabine 6 durvalumab 6 Bevacizumab 6 Radiotherapy, Intensity-Modulated 4 LMB-100 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 spartalizumab 3 olaparib 3 niraparib 3 atezolizumab 3 anetumab ravtansine 3 amatuximab 3 Vinorelbine 3 Paclitaxel 3 Imatinib Mesylate 3 Cerebral Decortication 3 tislelizumab 2 sargramostim 2 fludarabine phosphate 2 defactinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mesothelioma × dostarlimab × Clear all

NCT04940637 2023-05-12

UNITO-001

University of Turin, Italy

Phase 2 Unknown

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡